125 related articles for article (PubMed ID: 16714374)
1. Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration.
Chen X; Cui L; Duan X; Ma B; Zhong D
Drug Metab Dispos; 2006 Aug; 34(8):1345-52. PubMed ID: 16714374
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.
Huang JM; Weng WY; Huang XB; Ji YH; Chen E
Eur J Drug Metab Pharmacokinet; 2005; 30(3):165-70. PubMed ID: 16250252
[TBL] [Abstract][Full Text] [Related]
3. A UPLC-ESI-MS/MS Method for Simultaneous Quantitation of Chlorogenic Acid, Scutellarin, and Scutellarein in Rat Plasma: Application to a Comparative Pharmacokinetic Study in Sham-Operated and MCAO Rats after Oral Administration of
Chen S; Li M; Li Y; Hu H; Li Y; Huang Y; Zheng L; Lu Y; Hu J; Lan Y; Wang A; Li Y; Gong Z; Wang Y
Molecules; 2018 Jul; 23(7):. PubMed ID: 30037063
[No Abstract] [Full Text] [Related]
4. Sensitive liquid chromatography-tandem mass spectrometry method for the determination of scutellarin in human plasma: Application to a pharmacokinetic study.
Yulan S; Fang F
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):1-5. PubMed ID: 16269273
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic and tissue distribution study of scutellarin in rats].
You HS; Dong YL; Xing JF; Zhang CL; Wang MY
Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1688-92. PubMed ID: 18027669
[TBL] [Abstract][Full Text] [Related]
6. Absorption and disposition of scutellarin in rats: a pharmacokinetic explanation for the high exposure of its isomeric metabolite.
Gao C; Chen X; Zhong D
Drug Metab Dispos; 2011 Nov; 39(11):2034-44. PubMed ID: 21810967
[TBL] [Abstract][Full Text] [Related]
7. Two major urinary metabolites of scutellarin in rats.
Qiu F; Xia H; Zhang T; Di X; Qu G; Yao X
Planta Med; 2007 Apr; 73(4):363-5. PubMed ID: 17354170
[TBL] [Abstract][Full Text] [Related]
8. Metabolism profile of scutellarin in urine following oral administration to rats by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry.
Liu Q; Shi Y; Wang Y; Lu J; Cong W; Luo G; Wang Y
Talanta; 2009 Nov; 80(1):84-91. PubMed ID: 19782195
[TBL] [Abstract][Full Text] [Related]
9. Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC.
Huang J; Li N; Yu Y; Weng W; Huang X
J Pharm Biomed Anal; 2006 Feb; 40(2):465-71. PubMed ID: 16181763
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of scutellarin and its derivant scutellarin ethyl ester in rats].
Zhu LW; Liu XQ; Feng J; Gao HM; Yi H; Wang ZM; Meng QJ
Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(19):3373-7. PubMed ID: 24422411
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics and metabolites of scutellarin in normal and model rats].
Gao HM; Wang ZM; Tian J
Yao Xue Xue Bao; 2005 Nov; 40(11):1024-7. PubMed ID: 16499088
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.
Xing JF; You HS; Dong YL; Lu J; Chen SY; Zhu HF; Dong Q; Wang MY; Dong WH
Acta Pharmacol Sin; 2011 May; 32(5):655-63. PubMed ID: 21516133
[TBL] [Abstract][Full Text] [Related]
13. β-Glucuronidase- and OATP2B1-mediated drug interaction of scutellarin in Dengzhan Xixin Injection: A formulation aspect.
Shi J; Sun C; Huang H; Lin W; Gao J; Lin Y; Zhang Z; Huo X; Tian X; Yu Z; Zhang B; Ma X
Drug Dev Res; 2020 Aug; 81(5):609-619. PubMed ID: 32220026
[TBL] [Abstract][Full Text] [Related]
14. Dual Effect of Glucuronidation of a Pyrogallol-Type Phytophenol Antioxidant: A Comparison between Scutellarein and Scutellarin.
Liu Q; Li X; Ouyang X; Chen D
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563286
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of three glucuronide conjugates of scutellarein in rat plasma by LC-MS/MS for pharmacokinetic study of breviscapine.
Wang X; Xia H; Liu Y; Qiu F; Di X
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():79-84. PubMed ID: 24999248
[TBL] [Abstract][Full Text] [Related]
16. [Effect of pravastatin on transportation of scutellarin in mouse liver and its mechanism].
Liu JM; Xiong YQ
Yao Xue Xue Bao; 2011 Mar; 46(3):269-73. PubMed ID: 21626779
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interaction between scutellarin and valsartan in rats.
Cui MY; Tian CC; Ju AX; Zhang CT; Li QH
Yao Xue Xue Bao; 2013 Apr; 48(4):541-6. PubMed ID: 23833943
[TBL] [Abstract][Full Text] [Related]
18. [Study on the pharmacokinetics of scutellarin in dogs].
Jiang XH; Li SH; Lan K; Yang JY; Zhou J
Yao Xue Xue Bao; 2003 May; 38(5):371-3. PubMed ID: 12958843
[TBL] [Abstract][Full Text] [Related]
19. [Advances in studies on pharmacokinetics of scutellarin and scutellarein].
Liu J; Xiong Y
Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3165-8. PubMed ID: 20352990
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic studies on the absorption and disposition of scutellarin in humans: selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics.
Gao C; Zhang H; Guo Z; You T; Chen X; Zhong D
Drug Metab Dispos; 2012 Oct; 40(10):2009-20. PubMed ID: 22822035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
